Heron Therapeutics Inc. (HRTX)
NASDAQ: HRTX
· Real-Time Price · USD
1.32
-0.01 (-0.75%)
At close: Aug 18, 2025, 10:40 AM
-0.75% (1D)
| Bid | 1.15 |
| Market Cap | 202.35M |
| Revenue (ttm) | 148.52M |
| Net Income (ttm) | -7.79M |
| EPS (ttm) | -0.01 |
| PE Ratio (ttm) | -132 |
| Forward PE | 18.79 |
| Analyst | Buy |
| Ask | 1.51 |
| Volume | 437,679 |
| Avg. Volume (20D) | 1,542,680 |
| Open | 1.33 |
| Previous Close | 1.33 |
| Day's Range | 1.31 - 1.35 |
| 52-Week Range | 1.04 - 2.68 |
| Beta | 1.16 |
About HRTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HRTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for HRTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Heron Therapeutics has released their quartely earnings
on Aug 8, 2025:
Next Earnings Release
Heron Therapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-28.26%
Heron Therapeutics shares are trading lower after ...
Unlock content with
Pro Subscription
3 months ago
+13.62%
Heron Therapeutics shares are trading higher after the company reported better-than-expected Q1 financial results.
